SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported): December 7,
2009
POWER3
MEDICAL PRODUCTS, INC.
(Exact
Name of Registrant as Specified in Charter)
New
York
(State
or Other Jurisdiction
of
Incorporation)
|
000-24921
(Commission
File
Number)
|
65-0565144
(IRS
Employer
Identification
No.)
|
3400
Research Forest Drive, Suite B2-3
The
Woodlands, Texas
(Address
of Principal Executive Offices)
|
77381
(Zip
Code)
|
Registrant’s
telephone number, including area code: (281) 466-1600
(Former
Name or Former Address, if Changed Since Last Report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General
Instruction A.2. below):
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Section
5 – Corporate Governance and Management
Item
5.02
|
Departure
of Directors or Certain Officers; Election of Directors; Appointment of
Certain Officers; Compensatory Arrangements of Certain
Officers.
|
On December 7, 2009, John P. Ginzler
resigned as the Chief Financial Officer of Power3 Medical Products, Inc. (the
“Company”). On the same date, the Company appointed Helen R. Park,
who currently serves as the Company’s Chief Executive Officer, as its interim
Chief Financial Officer.
The
Company is not making any changes to the current compensation arrangement for
Ms. Park in connection with her appointment as interim Chief Financial Officer
of the Company.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
POWER3
MEDICAL PRODUCTS, INC.
|
|
Dated:
December 10, 2009
|
/s/
Helen R.
Park
|
Helen
R. Park
|
|
Chief
Executive Officer
|